Health Care & Life Sciences » Biotechnology | Beijing Tiantan Biological Products Corp. Ltd.

Beijing Tiantan Biological Products Corp. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
461,481.90
226,155.90
115,581.50
296,211.70
1,246,034.20
735,896.50
Depreciation, Depletion & Amortization
92,254.40
111,553.10
196,087.90
216,272.80
101,908.60
133,657.70
Other Funds
177,199.80
63,401.80
95,997.70
231,166.10
183,737.60
2,544.80
Funds from Operations
623,735.80
392,579.70
388,838.60
665,066.40
614,398.70
855,511.80
Changes in Working Capital
57,301.80
63,317.60
41,228.40
232,086.90
395,609.20
177,320
Net Operating Cash Flow
566,434.00
329,262.10
347,610.20
432,979.50
218,789.40
678,191.90
Capital Expenditures
548,371.00
464,156.80
300,574.50
217,411.30
144,872.80
Sale of Fixed Assets & Businesses
2,669.50
39.40
355.00
139.30
1,691,571.00
Net Investing Cash Flow
500,348.10
463,041.80
300,219.50
222,292.00
1,507,708.20
Cash Dividends Paid - Total
-
-
-
-
309,280.10
Issuance/Reduction of Debt, Net
384,851.40
484,722.60
345,869.50
86,140.00
80,000.00
Net Financing Cash Flow
207,651.60
421,320.80
441,867.20
145,026.20
573,017.80
Net Change in Cash
271,342.60
285,828.10
388,437.40
73,916.50
1,145,193.50
Free Cash Flow
18,062.90
134,894.70
47,035.70
215,568.20
73,916.70
Deferred Taxes & Investment Tax Credit
2,196.70
13,421.70
5,892.00
10,104.50
7,377.60
16,587.10
Net Assets from Acquisitions
-
-
-
5,020.00
10,990.00
Other Sources
45,353.40
1,075.60
-
-
-
Exchange Rate Effect
2,394.80
1,713.00
6,039.10
8,255.30
8,286.40
Other Uses
-
-
-
-
28,000.00

About Beijing Tiantan Biological Products Corp.

View Profile
Address
No.4 Sanjianfang South Li
Beijing Beijing 100024
China
Employees -
Website http://www.tiantanbio.com
Updated 07/08/2019
Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production, and sale of biological products. It offers blood albumin; intravenous, hepatitis B and tetanus immunoglobulin; coagulation factors; and protease inhibitors. The company was founded on June 8, 1998 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.